YX3-31251-85772
5 vaccinations
8 coded responses
53 check-ins
8 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 943 / CA
- Registered
- 2021-03-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-01
Dose 1 — Pfizer-BioNTech
-
2021-03-03
Registered in v-safe
- 2021-03-03
-
2021-03-04
Survey response — days 1–6 daily, dose 1MedDRA: Unevaluable event — Feeling: Good · Fatigue or tirednessFree text: Acyclovir interaction question: I started to take Acyclovir tablets last night for a mouth blister. After taking 3 tablets, I realized there could be potential for interaction or reduced vaccine efficacy. I stopped taking them and asked doctor. Should I be concerned about impact on vaccine efficacy?MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-10
- 2021-03-15
- 2021-03-22
-
2021-03-29
Dose 2 — Pfizer-BioNTech
- 2021-03-29
- 2021-03-30
-
2021-03-31
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pain — Feeling: Good · Muscle or body achesFree text: Tenderness at armpit of injection site arm. Some tenderness at neck near shouldersMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-01
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain — Feeling: Good · Muscle or body achesFree text: Only some tenderness around lymph nodes near jaw and ear jointsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-12
- 2021-04-19
- 2021-04-26
- 2021-05-03
- 2021-05-10
- 2021-06-28
- 2021-09-27
-
2021-09-29
Dose 3 — Pfizer-BioNTech
- 2021-09-30
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-11
- 2021-12-30
-
2022-03-29
Dose 4 — Moderna
-
2022-03-30
Survey response — 6 months, dose 3MedDRA: Dizziness, Gastroenteritis viral, SARS-CoV-2 test negative — Feeling: Good · Be unable to do your normal daily activitiesFree text: Had a 24 hour stomach/dizzy bug a few weeks ago. Possibly norovirus(?) Tested negative for COVID-19MedDRA releases: 2024-11 · check-in free text available
- 2022-04-14
- 2022-04-19
- 2022-04-26
- 2022-05-04
- 2022-05-10
- 2022-06-28
-
2022-09-07
Dose 5 — Pfizer-BioNTech
-
2022-09-11
Survey response — days 1–6 daily, dose 5MedDRA: SARS-CoV-2 test positive — Feeling: Fair · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Tested positive for COVID-19 the next dayMedDRA releases: 2024-11 · check-in free text available
-
2022-09-12
Survey response — days 1–6 daily, dose 5MedDRA: SARS-CoV-2 test positive — Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Tested positive for COVID-19 day after boosterMedDRA releases: 2024-11 · check-in free text available
-
2022-09-13
Survey response — days 1–6 daily, dose 5MedDRA: Laboratory test abnormal — Feeling: Fair · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Tested positive day after boosterMedDRA releases: 2024-11 · check-in free text available
-
2022-09-14
Survey response — day 7, dose 5MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Still positive for COVID-19MedDRA releases: 2024-11 · check-in free text available
- 2022-09-21
- 2022-09-28
- 2022-10-05
- 2022-10-12
- 2022-12-07
- 2023-03-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-01 | Pfizer-BioNTech | |
| 2 | 2021-03-29 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
| 4 | 2022-03-29 | Moderna | No |
| 5 | 2022-09-07 | Pfizer-BioNTech | No |
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Acyclovir interaction question: I started to take Acyclovir tablets last night for a mouth blister. After taking 3 tablets, I realized there could be potential for interaction or reduced vaccine efficacy. I stopped taking them and asked doctor. Should I be concerned about impact on vaccine efficacy?
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Tenderness at armpit of injection site arm. Some tenderness at neck near shoulders
Systemic reaction (other): Only some tenderness around lymph nodes near jaw and ear joints
Release 11 — 6 months, dose 3
Symptoms: Had a 24 hour stomach/dizzy bug a few weeks ago. Possibly norovirus(?) Tested negative for COVID-19
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): Tested positive for COVID-19 the next day
Systemic reaction (other): Tested positive for COVID-19 day after booster
Systemic reaction (other): Tested positive day after booster
Release 12 — day 7, dose 5
Systemic reaction (other): Still positive for COVID-19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | · | · | ✓ |
| SD | Gastroenteritis viral | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | COVID-19 | · | · | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Laboratory test abnormal | · | · | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release